These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3038385)

  • 1. Angiotensin-converting enzyme inhibitors: accomplishments and challenges.
    Petrillo EW; Powell JR; Cushman DW; Ondetti MA
    Clin Exp Hypertens A; 1987; 9(2-3):235-41. PubMed ID: 3038385
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity.
    Ondetti MA
    Circulation; 1988 Jun; 77(6 Pt 2):I74-8. PubMed ID: 2836111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
    Cecchi R; Ciabatti R; Favara D; Barone D; Baldoli E
    Farmaco Sci; 1985 Aug; 40(8):541-54. PubMed ID: 2995119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
    Krapcho J; Turk C; Cushman DW; Powell JR; DeForrest JM; Spitzmiller ER; Karanewsky DS; Duggan M; Rovnyak G; Schwartz J
    J Med Chem; 1988 Jun; 31(6):1148-60. PubMed ID: 2836590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
    Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ
    Neuropharmacology; 1991 Aug; 30(8):907-14. PubMed ID: 1664073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
    Harding P; Stonier C; Aber GM
    Clin Sci (Lond); 1991 Oct; 81(4):491-7. PubMed ID: 1657495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New potent inhibitors of angiotensin converting enzyme.
    Attwood MR; Francis RJ; Hassall CH; Kröhn A; Lawton G; Natoff IL; Nixon JS; Redshaw S; Thomas WA
    FEBS Lett; 1984 Jan; 165(2):201-6. PubMed ID: 6319181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo.
    Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL
    Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
    Gubert S; Braso MA; Sacristán A; Ortiz JA
    Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors.
    Robertson JM; Harding S; Grupp LA
    Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid.
    Reynolds CH
    Biochem Pharmacol; 1984 Apr; 33(8):1273-6. PubMed ID: 6324821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
    Hanessian S; Reinhold U; Saulnier M; Claridge S
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2123-8. PubMed ID: 9873498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors.
    Soudijn W
    Pharm Weekbl Sci; 1982 Oct; 4(5):154-8. PubMed ID: 6292819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
    Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E
    Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.